A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug target
The identification of new drug targets is highly challenging, particularly for diseases of the brain. This study describes a general computational gene regulatory framework called CRAFT for drug target discovery, and the authors use CRAFT to identify the microglial membrane receptor Csf1R as a poten...
Enregistré dans:
Auteurs principaux: | Prashant K. Srivastava, Jonathan van Eyll, Patrice Godard, Manuela Mazzuferi, Andree Delahaye-Duriez, Juliette Van Steenwinckel, Pierre Gressens, Benedicte Danis, Catherine Vandenplas, Patrik Foerch, Karine Leclercq, Georges Mairet-Coello, Alvaro Cardenas, Frederic Vanclef, Liisi Laaniste, Isabelle Niespodziany, James Keaney, Julien Gasser, Gaelle Gillet, Kirill Shkura, Seon-Ah Chong, Jacques Behmoaras, Irena Kadiu, Enrico Petretto, Rafal M. Kaminski, Michael R. Johnson |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c0cffc3635504945bbe2f39f8175da2f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
High prevalence of drug resistance in animal trypanosomes without a history of drug exposure.
par: Simbarashe Chitanga, et autres
Publié: (2011) -
Network neighbors of drug targets contribute to drug side-effect similarity.
par: Lucas Brouwers, et autres
Publié: (2011) -
Drugs
Publié: (1971) -
DrugEx v2: de novo design of drug molecules by Pareto-based multi-objective reinforcement learning in polypharmacology
par: Xuhan Liu, et autres
Publié: (2021) -
A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities
par: Ravi S. Narayan, et autres
Publié: (2020)